GLP-1 Maintenance Dose After Weight Loss: How to Transition

You have hit your goal weight. The hard part is done. Now comes a question that feels deceptively simple: what dose do you stay on?

This page walks you through the practical process of moving from your active weight loss dose to a maintenance dose that you can sustain long-term. This is the bridge between active treatment and the long-term management of your results.

When your provider identifies the transition point

The transition to maintenance is not automatic. It requires a conversation with your provider, and ideally, it happens before you are already at goal weight.

Most people do not have a single fixed goal weight. Instead, the transition point is determined by several factors working together:

You might have reached a specific target weight that you and your provider discussed at the beginning of treatment. You might have achieved a target BMI or a weight range that falls comfortably within what is considered healthy for your height and frame. You might have noticed that your metabolic markers (glucose, lipids, inflammation) have improved and you are seeing the results you were aiming for. Or you might have simply reached a point where you are satisfied with how you look and feel, and further weight loss is not your primary goal.

What matters is that you and your provider have this conversation proactively. The best time to discuss the transition is not at the appointment when you have already hit the number. It is a few weeks or months before, when you are trending toward goal. This gives you time to prepare, to think through your options, and to plan the next step with your provider.

The gradual dose reduction approach

First, the label facts. For semaglutide for weight management (Wegovy), the FDA label lists 2.4 mg weekly as the recommended maintenance dose and 1.7 mg as an alternative; the current label also allows some people to increase to a maximum of 7.2 mg weekly. For tirzepatide (Zepbound), the label lists 5 mg, 10 mg, or 15 mg weekly for weight reduction and long-term maintenance.^[3] Ongoing use below those doses is off-label. In the main maintenance trials, people stayed on their full dose: in SURMOUNT-4, participants continued their maximum tolerated tirzepatide dose of 10 or 15 mg.^[2]

So for many people, “maintenance” simply means staying at a labeled maintenance dose. Some providers, though, step the dose down gradually after goal weight, pausing at each step to assess whether weight stays stable. The evidence on this approach is much thinner than the evidence for staying on a full dose, which is a good reason to make the decision with a licensed provider.

When a provider does step down, the principle is straightforward: the dose is reduced in increments, often several weeks to a few months apart. At each dose level, you hold that dose and monitor what happens. Is your weight staying stable within a narrow range (typically 3 to 5 pounds of your goal)? Is your appetite manageable? Are side effects improving? If everything looks good after a period at that level, the provider may step down again.

The process continues until you and your provider identify the lowest dose at which your weight remains stable with acceptable side effects. That becomes your maintenance dose.

Example reduction schedule for semaglutide

For context, here is what a semaglutide step-down might look like. This is an illustration, not a standard protocol: doses below 1.7 mg for ongoing weight maintenance are off-label. Your actual plan, if any, will be determined by your provider and your individual response.

Example reduction schedule for tirzepatide

Tirzepatide doses are measured on a different scale than semaglutide doses, so the milligram numbers are not comparable between the two. The tirzepatide label lists 5, 10, or 15 mg as maintenance doses; 7.5 mg and 12.5 mg are dose-escalation steps, and anything below 5 mg for ongoing maintenance is off-label.

Important: These are illustrations. Your provider determines whether to step down at all, and the actual schedule, based on your response, your starting dose, your starting weight, and other factors. The goal is not to follow a standard chart. The goal is to find the dose that keeps your weight stable with side effects you can live with.

What to monitor during the transition

At each dose step, you are assessing several things. This is why the transition process takes time and involves regular contact with your provider.

Weight: Is your weight holding stable within 3 to 5 pounds of goal over several weeks at the lower dose? Some fluctuation week-to-week is normal due to water retention, cycle, and digestion. What matters is the overall trend. If your trend is stable or slightly downward, you are in good shape to stay at that dose.

Appetite and food noise: Is the constant mental urge to eat returning? Is it manageable, or is it becoming overwhelming? At a dose that is working for maintenance, appetite should feel manageable, without intense cravings or constant food thoughts. If appetite is returning significantly at a particular dose level, that dose may be too low.

Energy and wellbeing: Are you maintaining the energy you need to carry out your day? Are you maintaining the lifestyle habits that got you to goal weight in the first place? Strength training, walking, work stress management, sleep? The medication is the support layer, but your lifestyle choices are the foundation.

Labs: Your provider may monitor your metabolic health. Glucose, lipids, liver function, kidney function: the markers checked during active treatment can stay relevant. Whether and when labs are checked depends on your health history and on the provider, who may order them at transition points or more often if there is something specific to watch.

What “maintenance” actually means in practice

At a true maintenance dose, something important has shifted in your goal. You are no longer trying to lose more weight. The medication is providing enough GLP-1 receptor activation to support weight stability. It is the difference between the gas pedal pressed fully down (active weight loss) and the cruise control set to a steady speed (maintenance).

Side effects often ease once the dose is no longer going up. Nausea and constipation that may have been noticeable during dose escalation often become milder at a steady dose. They do not disappear for everyone, and the medication’s warnings still apply at any dose, so keep reporting symptoms to your provider. Many people find maintenance easier to live with than active treatment.

At maintenance, check-ins are often less frequent than during active treatment, but you should not be on your own. How often a provider follows up varies by program; ask what to expect, so that if something shifts, you catch it early.

When maintenance dose is not holding

Sometimes you reach a dose level and discover that weight starts to drift upward. This is actually valuable information.

If your weight begins to increase above your goal at a particular dose level, talk with your provider before reducing further. The tendency is to think “my weight is going up, I need less medication,” but the issue might be the opposite. You may have found the lowest dose that maintains your weight. Reducing further could trigger more significant regain.

This is the maintenance floor for your body. Some people stay indefinitely at what seems like a “high” maintenance dose because that is the lowest dose at which their body maintains stable weight. That is completely fine. There is no prize for the lowest dose.

Seasonal and life-event-related weight fluctuations are normal. The question is trend, not a single weigh-in. If you are consistently drifting 5 to 10 pounds above goal and it is not coming back down within a few weeks, that is a signal to discuss with your provider. If you had a stressful week and gained 2 pounds, and it is back off in two weeks, that is just life.

What to check before using a GLP-1 maintenance dose

If you have reached goal weight or are ready to move to maintenance, the plan, and what it costs, depends on the provider and program you choose. Programs handle maintenance very differently, so it is worth asking before you change anything.

Compare the total cost, not the headline number. Ask about:

• The medication itself, and whether the price changes when your dose goes down (some programs price by dose; others charge a flat fee whatever the dose)
• Provider visits and follow-ups, and how often they happen during maintenance
• Lab work, and whether it is included or billed separately
• Coaching or nutrition support, if you want it, and whether it costs extra
• Shipping, membership fees, and cancellation terms

Who this tends to fit

• People who have completed a period of active treatment and are at or near goal weight
• People who want to hold their results and are open to staying on some dose rather than stopping outright
• Whether medication remains appropriate for you is a clinical decision a licensed provider makes based on your history

How it works

At most telehealth programs, a licensed provider reviews your health history, how you responded to treatment, and your goals, and decides whether a prescription, and at what dose, is appropriate. Some states require a live video visit before a first prescription can be written; if that applies where you live, the provider you choose will tell you.

Questions worth bringing to whichever provider you are considering:

• Do you recommend staying at a labeled maintenance dose, or stepping down? Why?
• If we step down, how long will we hold each level, and what will tell us to stop reducing?
• Is the medication you prescribe an FDA-approved brand-name product or compounded, and which pharmacy prepares it?
• What is the plan if my weight starts to come back?

The role of lifestyle habits in maintenance

Habits you built during active treatment matter more once the dose comes down.

During your weight loss phase, the medication created a window. That window gave you the biological support to reduce your appetite enough that you could consistently eat fewer calories than your body was using. In that calorie deficit, you learned. You experimented with higher protein, with skipping ultra-processed foods, with moving your body in ways that felt good. You built practices around stress, sleep, hydration. The medication made it possible, but you did the work.

Maintenance is where those practices prove their value. A lower maintenance dose is a lower-intensity support. It keeps the biological signals steady, but it is not muscling your appetite down the way active treatment did. This is where the lifestyle foundation you built helps sustain your results.

Be realistic about what habits can do on their own, though. Regain after stopping is largely biological, not a willpower failure. In the STEP 1 trial extension, people who stopped semaglutide (and the trial’s lifestyle program) regained about two-thirds of the weight they had lost within a year.^[4] In SURMOUNT-4, people switched to placebo after 36 weeks of tirzepatide regained 14.0% of their body weight over the next year, while those who stayed on tirzepatide lost a further 5.5% on average.^[2] STEP 4 showed the same pattern for semaglutide.^[1] Results vary, and trial results describe study participants, not what will happen to you. People who hold their results long-term often do it by staying on medication at some dose while keeping their habits in place.

Some programs include coaching during maintenance; others do not. Either way, the goal is not restriction or “staying on track.” It is about maintaining the eating patterns, movement practices, and stress management that worked during your weight loss phase, not perfectly, just consistently.

Citations

[1] Rubino D, et al. “Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.” JAMA 2021;325(14):1414-1425. https://pubmed.ncbi.nlm.nih.gov/33755728/

[2] Aronne LJ, et al. “Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.” JAMA 2024;331(1):38-48. https://pubmed.ncbi.nlm.nih.gov/38078870/

[3] Novo Nordisk. Wegovy (semaglutide) prescribing information, section 2.2 (label dated 2026-06-18). https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf ; Eli Lilly and Company. Zepbound (tirzepatide) prescribing information, section 2.2 (label dated 2026-09-10). https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf

[4] Wilding JPH, et al. “Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.” Diabetes Obes Metab 2022;24(8):1553-1564. https://pubmed.ncbi.nlm.nih.gov/35441470/

Key takeaways

The labels for the approved products list maintenance doses (2.4 mg or 1.7 mg for semaglutide for weight management; 5, 10, or 15 mg for tirzepatide), and the main trials kept people on their full dose. Staying at a labeled maintenance dose is one option. Some providers step the dose down gradually instead, holding each level to assess weight stability and how you feel; below the labeled maintenance doses, that is off-label.

At each step, you and your provider watch weight, appetite, energy, and, where needed, labs. The goal is to find a dose that maintains your weight with acceptable side effects and that you can sustain long-term.

For many people, maintenance turns out to be more comfortable than active treatment. Side effects often ease and weight can stabilize, though results vary and stopping completely usually leads to regain.

Whatever you decide, make the plan with a licensed provider, and compare what programs include and charge for maintenance before you commit.